Kusumoto, Shigeru, and Takayoshi Tachibana. 2020. “Central Nervous System Management Remains an Evidence Gap in First-Line Tagraxofusp Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm. Comment On: ‘First-Line Tagraxofusp Leads to Durable Responses and Prolonged Survival in Adults With Blastic Plasmacytoid Dendritic Cell Neoplasm Regardless of Fitness level’”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301865.